| Mount Pilchuck Eyecare | |
|
8713 64th St Ne, Marysville, WA 98270-7704 | |
| (813) 310-9238 | |
| Not Available |
| Full Name | Mount Pilchuck Eyecare |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 8713 64th St Ne, Marysville, Washington |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326618026 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Prajakta N Joshi |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1437640547 PECOS PAC ID: 6002243292 Enrollment ID: I20200228000308 |
News Archive
A newly discovered cellular messaging mechanism could lead to a new way to deliver therapeutics to tissues affected by disease, according to a new study from Harvard T.H. Chan School of Public Health.
A new study led by the University of Minnesota Medical School and the University of Washington School of Public Health looks to solve cervical cancer disparities among Somali women.
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
Cancer Research UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won't benefit from commonly used chemotherapy drugs.
› Verified 8 days ago
| Provider Name | Kulvir Singh Kainth |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1881116994 PECOS PAC ID: 3274922687 Enrollment ID: I20211104002895 |
News Archive
A newly discovered cellular messaging mechanism could lead to a new way to deliver therapeutics to tissues affected by disease, according to a new study from Harvard T.H. Chan School of Public Health.
A new study led by the University of Minnesota Medical School and the University of Washington School of Public Health looks to solve cervical cancer disparities among Somali women.
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
Cancer Research UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won't benefit from commonly used chemotherapy drugs.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mount Pilchuck Eyecare 8713 64th St Ne, Marysville, WA 98270-7704 Ph: (813) 310-9238 | Mount Pilchuck Eyecare 8713 64th St Ne, Marysville, WA 98270-7704 Ph: (813) 310-9238 |
News Archive
A newly discovered cellular messaging mechanism could lead to a new way to deliver therapeutics to tissues affected by disease, according to a new study from Harvard T.H. Chan School of Public Health.
A new study led by the University of Minnesota Medical School and the University of Washington School of Public Health looks to solve cervical cancer disparities among Somali women.
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
Cancer Research UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who won't benefit from commonly used chemotherapy drugs.
› Verified 8 days ago
Dr. Kristin A. Colonna, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2335 172nd St Ne, Marysville, WA 98271 Phone: 360-651-1550 | |
Dr. Jennifer Marie Christman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 | |
Cody Good, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 | |
Marysville Vision Source Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 Fax: 360-653-2466 | |
Dr. Emily Camchau Do Nguyen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16616 Twin Lakes, Marysville, WA 98271 Phone: 360-652-4543 Fax: 360-652-4544 | |
Daniel Samaniego, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1262 State Ave, Marysville, WA 98270 Phone: 360-651-7450 | |
Eye Doctors Ltd Ps Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1083 Cedar Ave, Marysville, WA 98270 Phone: 360-659-1446 Fax: 360-659-7324 |